How to Look at Private Equity Investment in Physician Groups: Dermatology

Healio

Gary W. Herschman, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Newark office, authored an article in Healio, titled “How to Look at Private Equity Investment in Physician Groups: Dermatology.” (Part one of a six part series.)

Following is an excerpt:

Private equity investment activity in dermatology has been particularly robust since 2012, when private equity capital first began to pour into the sector. Private equity firms’ investment theses were, and continue to be, predicated on macroeconomic growth drivers, such as an increase in skin cancer incidence, skin health awareness, and favorable payor mix dynamics. These trends, coupled with ancillary services, such as cosmetics, surgery centers, and lab services, have increased the demand for the sector at a rapid pace.